Animal Pharm is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By



Set Alert for Investments

Latest From Investments

SomaDetect raises $2m seed funding, plans North America data collection expansion

Canadian dairy health technology specialist SomaDetect has completed its most recent seed funding round, raising $2 million. 

Equipment & Technology Investments

PanTheryx funding will help intensify growth in animal microbiome-focused products

Boulder, Colorado-based PanTheryx is focused on addressing gastrointestinal microbiome-related health conditions in humans and animals. Animal Pharm editor Joseph Harvey spoke to the company's executive vice president George Stagnitti about how it is bringing a science-backed approach to the animal nutrition sector.

Feed & Additives Food Animals

Evonik invests in US fund for east coast focus

Evonik Industries' venture capital arm has invested in a US fund, in order to access new technologies.

Investments United States

Proteon awarded grant to develop aqua bacteriophage

Polish bacteriophage specialist Proteon Pharmaceuticals has secured a €2.9 million ($3.2 million) grant from the European Regional Development Fund.

Investments Feed & Additives

Agrivida secures $8m to reinforce commercial efforts for sustainable feed additive

US feed additive start-up Agrivida has followed a recent US FDA approval with the closing of the first stage of a $20 million investment round.

Investments Feed & Additives

PetCure plans IPO to boost US cancer radiosurgery business

US company PetCure Oncology has enlisted an investment banking firm to help it pursue an initial public offering (IPO). 

Investments Companion Animals
See All